News

GSK is putting the finishing touches on its case for antibody-drug conjugate Blenrep with a key progression-free survival ...
Havas Media Network has set up an advertising marketplace to help companies reach patients who are cut off from healthcare by ...
Nine years after selling Medivation to Pfizer for $14 billion, David Hung, M.D., is going toe to toe with the New York ...
Despite an outcry from the biopharmaceutical industry, the U.K. government has kept the rebate rate under a national ...
Hoping to gain an edge in the rapidly growing market are MilliporeSigma and Simtra BioPharma Solutions, which have forged a ...